Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ORPH | AMGN | BMY | VRTX | GILD |
| Company | Orphazyme A/S ADR | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 0.9060 | 288.28 | 58.00 | 452.44 | 88.80 |
| High | 0.9571 | 288.28 | 58.00 | 452.44 | 88.80 |
| Low | 0.8457 | 288.28 | 58.00 | 452.44 | 88.80 |
| Last | 0.8700 | 288.28 | 58.00 | 452.44 | 88.80 |
| Change | -0.0200 | +0.41 | +0.12 | +1.21 | +0.17 |
| % Change | -2.25% | +0.14% | +0.21% | +0.27% | +0.19% |
| Volume | 941,400 | 2,253 | 4,373 | 504 | 2,658 |
| 20-Day Average Volume | 1,980,090 | 2,745,308 | 12,026,523 | 1,270,425 | 7,326,403 |
| Previous Close | 0.8900 | 287.87 | 57.88 | 451.23 | 88.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.9128 | 307.34 | 55.91 | 479.34 | 90.84 |
| 20-Day Raw Stochastic | 41.76% | 24.14% | 66.77% | 9.47% | 21.22% |
| 20-Day Relative Strength | 36.52% | 35.20% | 60.20% | 41.60% | 51.44% |
| Weighted Alpha | -87.89 | +1.14 | +25.37 | +18.82 | +24.21 |
| Today's Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Previous Opinion | 100% Sell | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 100% Sell | 8% Buy | 88% Buy | 8% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.47% since 03/23/22 | -2.59% since 11/14/24 | -0.85% since 11/14/24 | -6.51% since 11/14/24 | -3.59% since 11/14/24 |
| Low | 0.8275 on 03/29/22 | 275.56 on 11/19/24 | 55.82 on 11/15/24 | 445.38 on 11/20/24 | 86.08 on 11/19/24 |
| High | 0.9600 on 03/29/22 | 291.50 on 11/15/24 | 58.83 on 11/20/24 | 479.93 on 11/15/24 | 91.99 on 11/15/24 |
| 1-Month | |||||
| %Chg | -28.69% since 02/28/22 | -8.99% since 10/21/24 | +11.28% since 10/21/24 | -5.37% since 10/21/24 | +2.91% since 10/21/24 |
| Low | 0.5101 on 03/14/22 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.38 on 11/20/24 | 85.60 on 10/22/24 |
| High | 1.3720 on 03/10/22 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | -67.29% since 12/28/21 | -12.42% since 08/21/24 | +19.74% since 08/21/24 | -6.93% since 08/21/24 | +18.20% since 08/21/24 |
| Low | 0.5101 on 03/14/22 | 275.56 on 11/19/24 | 46.88 on 08/22/24 | 445.38 on 11/20/24 | 75.35 on 08/22/24 |
| High | 2.7500 on 01/03/22 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | -79.33% since 09/28/21 | -8.44% since 05/21/24 | +37.21% since 05/21/24 | +2.36% since 05/21/24 | +31.97% since 05/21/24 |
| Low | 0.5101 on 03/14/22 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 5.4900 on 10/13/21 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 30,721 | 154,739,632 | 117,390,888 | 116,204,808 | 110,456,552 |
| Shares Outstanding, K | 35,312 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 0 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -97,010,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | N/A | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | N/A | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.68 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 04/05/22 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.57 | 49.77 | 0.00 | 19.81 |